Based on previous observations made in metastatic BC patients [34], we hypothesized that an increased frequency of circulating CD11b+ cells expressing CD117 and/or displaying a M2 activation phenotype may also occur in patients with early BC. The gene discussed is KIT; the disease is breast cancer.